Palbociclib/Letrozole Improves Survival in HR+ Metastatic Breast Cancer
Oncology Nursing News,
Palbociclib in combination with endocrine therapy resulted in improved survival outcomes in a real-world population of patients…
Palbociclib in combination with endocrine therapy resulted in improved survival outcomes in a real-world population of patients…
Oncologia-Ematologia Cancro al seno metastatico HR+/HER2-, palbociclib/letrozolo in prima linea migliora la sopravvivenza anche…
Data published in Breast Cancer Research showed real-world efficacy of palbociclib (Ibrance) in combination with letrozole in…
Pfizer’s breast cancer drug Ibrance is under increased pressure from rival CDK4/6 inhibitors from Novartis and Eli Lilly thanks…